EATONTOWN, N.J., Feb. 14, 2025 /PRNewswire/ -- Avertix Medical, Inc. ("Avertix" or the "Company"), the developer of The Guardian® system - the world's first real-time, continuous heart attack detection and patient alerting system today announced compelling new data confirming the...
Read More Details
Finally We wish PressBee provided you with enough information of ( Avertix's Guardian System Confirmed as Cost-Effective for High-Risk Acute Coronary Syndrome Patients )
Also on site :
- Reform MP James McMurdock suspends himself from party over ‘business propriety during pandemic’
- Disturbed’s David Draiman Met with Some Boos at Final Black Sabbath Concert
- Police investigation underway on Boardman Street near Monroe Avenue